Status:
UNKNOWN
The Use of Furosemide in Patients on Dialysis
Lead Sponsor:
Unity Health Toronto
Conditions:
End Stage Renal Disease
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
Patients often begin dialysis taking diuretics (stimulate the kidney to excrete salt and water). Once on dialysis, these drugs are often continued. Whether these drugs are still needed, or even effect...
Detailed Description
Patients often begin dialysis on a significant dose of diuretic due to the retention of sodium and water in the predialysis phase of their chronic kidney disease (CKD). The quandary often faced by the...
Eligibility Criteria
Inclusion
- all patients taking Furosemide -
Exclusion
- Patients not willing to give consent
- \-
Key Trial Info
Start Date :
May 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2016
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT01815892
Start Date
May 1 2015
End Date
December 1 2016
Last Update
August 10 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St Michael's Hospital
Toronto, Ontario, Canada, M5B 1W8